These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

708 related articles for article (PubMed ID: 23415805)

  • 1. Magnetic resonance colonography for the detection of colorectal neoplasia in asymptomatic adults.
    Graser A; Melzer A; Lindner E; Nagel D; Herrmann K; Stieber P; Schirra J; Mansmann U; Reiser MF; Göke B; Kolligs FT
    Gastroenterology; 2013 Apr; 144(4):743-750.e2. PubMed ID: 23415805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of CT colonography, colonoscopy, sigmoidoscopy and faecal occult blood tests for the detection of advanced adenoma in an average risk population.
    Graser A; Stieber P; Nagel D; Schäfer C; Horst D; Becker CR; Nikolaou K; Lottes A; Geisbüsch S; Kramer H; Wagner AC; Diepolder H; Schirra J; Roth HJ; Seidel D; Göke B; Reiser MF; Kolligs FT
    Gut; 2009 Feb; 58(2):241-8. PubMed ID: 18852257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Community-based screening by colonoscopy or computed tomographic colonography in asymptomatic average-risk subjects.
    Scott RG; Edwards JT; Fritschi L; Foster NM; Mendelson RM; Forbes GM
    Am J Gastroenterol; 2004 Jun; 99(6):1145-51. PubMed ID: 15180739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic accuracy of computed tomographic colonography for the detection of advanced neoplasia in individuals at increased risk of colorectal cancer.
    Regge D; Laudi C; Galatola G; Della Monica P; Bonelli L; Angelelli G; Asnaghi R; Barbaro B; Bartolozzi C; Bielen D; Boni L; Borghi C; Bruzzi P; Cassinis MC; Galia M; Gallo TM; Grasso A; Hassan C; Laghi A; Martina MC; Neri E; Senore C; Simonetti G; Venturini S; Gandini G
    JAMA; 2009 Jun; 301(23):2453-61. PubMed ID: 19531785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of a guaiac based and an immunochemical faecal occult blood test in screening for colorectal cancer in a general average risk population.
    Guittet L; Bouvier V; Mariotte N; Vallee JP; Arsène D; Boutreux S; Tichet J; Launoy G
    Gut; 2007 Feb; 56(2):210-4. PubMed ID: 16891354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interval faecal occult blood testing in a colonoscopy based screening programme detects additional pathology.
    Bampton PA; Sandford JJ; Cole SR; Smith A; Morcom J; Cadd B; Young GP
    Gut; 2005 Jun; 54(6):803-6. PubMed ID: 15888788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of the immunochemical fecal occult blood test and total colonoscopy in the asymptomatic population.
    Morikawa T; Kato J; Yamaji Y; Wada R; Mitsushima T; Shiratori Y
    Gastroenterology; 2005 Aug; 129(2):422-8. PubMed ID: 16083699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunochemical faecal occult blood tests are superior to guaiac-based tests for the detection of colorectal neoplasms.
    Dancourt V; Lejeune C; Lepage C; Gailliard MC; Meny B; Faivre J
    Eur J Cancer; 2008 Oct; 44(15):2254-8. PubMed ID: 18760592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population.
    van Rossum LG; van Rijn AF; Laheij RJ; van Oijen MG; Fockens P; van Krieken HH; Verbeek AL; Jansen JB; Dekker E
    Gastroenterology; 2008 Jul; 135(1):82-90. PubMed ID: 18482589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low risk of colorectal cancer and advanced adenomas more than 10 years after negative colonoscopy.
    Brenner H; Haug U; Arndt V; Stegmaier C; Altenhofen L; Hoffmeister M
    Gastroenterology; 2010 Mar; 138(3):870-6. PubMed ID: 19909750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. One-time screening for colorectal cancer with combined fecal occult-blood testing and examination of the distal colon.
    Lieberman DA; Weiss DG;
    N Engl J Med; 2001 Aug; 345(8):555-60. PubMed ID: 11529208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colonoscopic screening of first-degree relatives of patients with large adenomas: increased risk of colorectal tumors.
    Cottet V; Pariente A; Nalet B; Lafon J; Milan C; Olschwang S; Bonaiti-Pellié C; Faivre J; Bonithon-Kopp C;
    Gastroenterology; 2007 Oct; 133(4):1086-92. PubMed ID: 17919484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Magnetic resonance colonography versus colonoscopy as a diagnostic investigation for colorectal cancer: a meta-analysis.
    Purkayastha S; Tekkis PP; Athanasiou T; Aziz O; Negus R; Gedroyc W; Darzi AW
    Clin Radiol; 2005 Sep; 60(9):980-9. PubMed ID: 16124980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Test performance of immunologic fecal occult blood testing and sigmoidoscopy compared with primary colonoscopy screening for colorectal advanced adenomas.
    Khalid-de Bakker CA; Jonkers DM; Sanduleanu S; de Bruïne AP; Meijer GA; Janssen JB; van Engeland M; Stockbrügger RW; Masclee AA
    Cancer Prev Res (Phila); 2011 Oct; 4(10):1563-71. PubMed ID: 21750209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A prospective comparison of video colonoscopy and CT colonography in asymptomatic patients screened for colorectal cancer].
    Juchems M; Römpp A; Kestler HA; Ernst A; Brambs HJ; Adler G; Aschoff A; Wagner M
    Dtsch Med Wochenschr; 2010 Aug; 135(34-35):1656-61. PubMed ID: 20721840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening for familial colorectal cancer with a sensitive immunochemical fecal occult blood test: a pilot study.
    Gimeno-García AZ; Quintero E; Nicolás-Pérez D; Hernández-Guerra M; Parra-Blanco A; Jiménez-Sosa A
    Eur J Gastroenterol Hepatol; 2009 Sep; 21(9):1062-7. PubMed ID: 19307978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of the immunochemical fecal test (FIT) for detection of advanced adenomas in colorectal carcinoma screening in an asymptomatic population.
    Miuţescu B; Sporea I; Popescu A; Bota S; Iovănescu D; Burlea A; Mos L; Palaghia M; Vasilescu A; Miuţescu E
    Rev Med Chir Soc Med Nat Iasi; 2013; 117(2):302-7. PubMed ID: 24340508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colonoscopic screening of average-risk women for colorectal neoplasia.
    Schoenfeld P; Cash B; Flood A; Dobhan R; Eastone J; Coyle W; Kikendall JW; Kim HM; Weiss DG; Emory T; Schatzkin A; Lieberman D;
    N Engl J Med; 2005 May; 352(20):2061-8. PubMed ID: 15901859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensitivity of immunochemical fecal occult blood test to small colorectal adenomas.
    Morikawa T; Kato J; Yamaji Y; Wada R; Mitsushima T; Sakaguchi K; Shiratori Y
    Am J Gastroenterol; 2007 Oct; 102(10):2259-64. PubMed ID: 17617203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness modeling of colorectal cancer: computed tomography colonography vs colonoscopy or fecal occult blood tests.
    Lucidarme O; Cadi M; Berger G; Taieb J; Poynard T; Grenier P; Beresniak A
    Eur J Radiol; 2012 Jul; 81(7):1413-9. PubMed ID: 21444171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.